Carr Patricia sold $327K of JAZZ
Carr Patricia (SVP, Chief Accounting Officer) sold 1,413 shares of Jazz Pharmaceuticals plc (JAZZ) at an average of $231.36 ($231.27–$231.37, $0.33M total) across 2 trades on 2026-11-04.
How this was made
The 30-second read
Why it matters
Provides fresh primary data on insider activity, useful for short‑term sentiment assessment.
Market read
Direct insider sale may cause slight price dip; relevance limited to short‑term traders.
What to watch
Overall company fundamentals remain strong; the sale size is small relative to market cap.
Background
SEC Form 4 filing by SVP and Chief Accounting Officer Patricia Carr discloses a $327K share sale.
Ticker impact
Form 4 shows insider sold 1,413 shares for $326,909, reducing holdings to 6,512 shares.
likely modest downward pressure as market prices in the insider sale
Insider sales by a senior officer often prompt short-term caution, especially when the transaction size is notable relative to holdings.
Market effects
Minimal impact on the broader pharmaceutical sector.
No significant regional effect.
Limited to investors tracking insider activity.
Counterpoint
The sale could be routine liquidity need, not a negative signal.
Key entities
- CompanyJazz Pharmaceuticals plc
Issuer of the Form 4 filing.
- ExecutivePatricia Carr
SVP, Chief Accounting Officer, insider seller.
